Aligos Therapeutics (ALGS) Net Equity Issued and Repurchased (2019 - 2025)
Aligos Therapeutics (ALGS) posted Net Equity Issued and Repurchased of $124,000 for Q4 2025, down 10.8% from $139,000 a year earlier.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Net Equity Issued and Repurchased (2019 - 2025) Analysis & Trends
For FY2025, Aligos Therapeutics' Net Equity Issued and Repurchased came in at $304,000, down 30.3% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -62.3% (FY2020 to FY2025).
- In prior years, Aligos Therapeutics' Net Equity Issued and Repurchased was $436,000 in FY2024 (-20.9%), $551,000 in FY2023 (+168.8%), $205,000 in FY2022 (-99.7%) and $79.63 million in FY2021 (+99.1%).
- The Q4 2025 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q4 2023.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2023, with growth of 333.7%; the weakest was Q4 2021, with a decline of 97.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 124,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Jun 30, 2023 | 461,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 74,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 112,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 720,000.00 |
| Sep 30, 2021 | 78.60 Mn |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 96,000.00 |
| Dec 31, 2020 | 578,000.00 |
| Sep 30, 2020 | 135,000.00 |
| Jun 30, 2020 | 44,000.00 |
| Mar 31, 2020 | 368,000.00 |
| Dec 31, 2019 | 317,000.00 |
API Access
Aligos Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();